Protamine Sulfate Injection, Solution
NDC 63323-229
Product Information
Protamine Sulfate is a ANDA-approved product labeled by Fresenius Kabi Usa, Llc. This medication is typically used as a heparin binding activity [moa]. It is supplied as a injection, solution for intravenous administration. This product entry covers the primary NDC 63323-229 and 7 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 63323-229?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PROTAMINE SULFATE (UNII: 0DE9724IHC)
- PROTAMINE (UNII: 72G3UY6T4N) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SULFURIC ACID (UNII: O40UQP6WCF)
- SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1796672 - protamine sulfate 50 MG in 5 ML Injection
- RxCUI: 1796672 - 5 ML protamine sulfate (USP) 10 MG/ML Injection
- RxCUI: 1796672 - protamine sulfate 50 MG per 5 ML Injection
- RxCUI: 1796676 - protamine sulfate 250 MG in 25 ML Injection
- RxCUI: 1796676 - 25 ML protamine sulfate (USP) 10 MG/ML Injection
Which are the Pharmacologic Classes of this product?
- Heparin Binding Activity - [MoA] (Mechanism of Action)
- Heparin Reversal Agent - [EPC] (Established Pharmacologic Class)
- Reversed Anticoagulation Activity - [PE] (Physiologic Effect)
- Heparin Binding Activity - [MoA] (Mechanism of Action)
- Heparin Reversal Agent - [EPC] (Established Pharmacologic Class)
- Reversed Anticoagulation Activity - [PE] (Physiologic Effect)
- Heparin Binding Activity - [MoA] (Mechanism of Action)
- Heparin Reversal Agent - [EPC] (Established Pharmacologic Class)
- Reversed Anticoagulation Activity - [PE] (Physiologic Effect)
* Please review the full disclaimer at the bottom of this page.